Trial intelligence / Profile preview

Perineural dexamethasone for prolongation of ulnar nerve block in healthy volunteers

2020-004242-10Phase 2Completed

Sponsor
Centre for Anaesthesiological Research, Zealand University Hospital
Start
Nov 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of dexamethasone and bupivacaine (2 arms), sponsored by Centre for Anaesthesiological Research, Zealand University Hospital. Primary endpoint: Duration of sensory nerve block by temperature discrimination. Started Nov 2020; status: completed.

02

Drugs

dexamethasonebupivacaine

Beyond the preview

Go deeper on 2020-004242-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-004242-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call